Zobrazeno 1 - 9
of 9
pro vyhledávání: '"D. M. Heijink"'
Autor:
D. M. Heijink, J. H. Kleibeuker, M. Jalving, W. Boersma-van Ekb, J. J. Koornstra, J. Wesseling, S. de Jong
Publikováno v:
Cellular Oncology, Vol 29, Iss 5, Pp 409-419 (2007)
Background: TNF-Related Apoptosis Inducing Ligand (TRAIL) is a promising agent for the induction of apoptosis in neoplastic tissues. Important determinants of TRAIL sensitivity are two intracellular proteins of the TRAIL pathway, caspase-8 and its an
Externí odkaz:
https://doaj.org/article/1bc75da155db41c583d474aba6fc12d8
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 165
A 65-year-old female complained of diffuse and rapidly progressive gingival enlargement. Gingival overgrowth can be caused by medication, infections or systemic diseases. In case of generalized, quickly progressive gingival enlargement, acute myeloid
Autor:
W. Boersma-van Ek, de Elisabeth G. E. Vries, Johannes Wesseling, D. M. Heijink, Jan J. Koornstra, Mathilde Jalving, Nynke Zwart, Jan H. Kleibeuker, de Steven Jong, Willem Sluiter
Publikováno v:
CARCINOGENESIS, 35(5), 1092-1099. Oxford University Press
Expression of the pro-apoptotic TRAIL receptors is regulated, at least in part, by beta-catenin. We show that beta-catenin co-localizes with DR4/5 in human and mouse colorectal tumours and that downregulation of beta-catenin in cell line models reduc
Publikováno v:
The Netherlands journal of medicine. 74(4)
CAR T-cells are autologous T-cells transduced with a chimeric antigen receptor (CAR). The CAR contains an antigen recognition part (originating from an antibody), a T-cell receptor transmembrane and cytoplasmic signalling part, and one or more co-sti
Autor:
Dorenda Oosterhuis, Wouter B. Nagengast, Elisabeth G.E. de Vries, D. M. Heijink, Adrienne H. Brouwers, Jan H. Kleibeuker, Steven de Jong, Jan J. Koornstra
Publikováno v:
Journal of Nuclear Medicine, 52(3), 431-436. SOC NUCLEAR MEDICINE INC
Apc mutant (Apc(Min)) mice develop multiple adenomas in their intestines and are widely used to study colorectal carcinogenesis and chemopreventive approaches. Molecular imaging of intestinal adenomas could potentially provide noninvasive longitudina
Autor:
Roelof Koster, Mathilde Jalving, Jan H. Kleibeuker, Dorenda Oosterhuis, Harry Hollema, D. M. Heijink, Elisabeth G.E. de Vries, Jan J. Koornstra, Steven de Jong, Ineke A. Sloots
Publikováno v:
The Journal of Pathology. 223:378-389
TNF-related apoptosis-inducing ligand (TRAIL) receptor agonistic agents and non-steroidal anti-inflammatory drugs (NSAIDs) are interesting agents for the chemoprevention and treatment of colorectal cancer. We investigated whether NSAIDs sensitize col
Autor:
de Steven Jong, Mathilde Jalving, Jelle Wesseling, W. Boersma-van Ek, Jan H. Kleibeuker, D. M. Heijink, Jan J. Koornstra
Publikováno v:
Cellular oncology, 29(5), 409-419. SPRINGER
Cellular Oncology, Vol 29, Iss 5, Pp 409-419 (2007)
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
Europe PubMed Central
Cellular Oncology, Vol 29, Iss 5, Pp 409-419 (2007)
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
Europe PubMed Central
Background: TNF-Related Apoptosis Inducing Ligand (TRAIL) is a promising agent for the induction of apoptosis in neoplastic tissues. Important determinants of TRAIL sensitivity are two intracellular proteins of the TRAIL pathway, caspase-8 and its an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f5f68b029302aecd00dca920afd0a5d
https://research.rug.nl/en/publications/3d431baf-0b38-4b55-b66a-8117271ec6ab
https://research.rug.nl/en/publications/3d431baf-0b38-4b55-b66a-8117271ec6ab
Autor:
Jan J. Koornstra, Elisabeth G.E. de Vries, Robert M.W. Hofstra, Geke A. P. Hospers, Marcel A. T. M. van Vugt, D. M. Heijink, Steven de Jong, Jan H. Kleibeuker
Publikováno v:
Critical Reviews in Oncology/Hematology. 80(2):264-277
Lynch syndrome (LS) is caused by a germline mutation in one of the mismatch repair (MMR) genes. The resulting loss of MMR gene function induces a strong mutator phenotype and predisposition to colorectal cancer (CRC). LS mutation carriers undergo reg
Autor:
de Elisabeth G. E. Vries, Dorenda Oosterhuis, Rudolf S N Fehrmann, D. M. Heijink, Jan J. Koornstra, van der Ate Zee, de Steven Jong, Jan H. Kleibeuker
Publikováno v:
ONCOGENE, 30(17), 2026-2036. Nature Publishing Group
Comparing normal colorectal mucosa and adenomas focusing on deregulated pathways obtains insight into the biological processes of early colorectal carcinogenesis. Publicly available microarray expression data from 26 normal mucosa and 47 adenoma samp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5cc04a6057cb33c1b700d39423d707
https://research.rug.nl/en/publications/69ec7c24-43b8-44b2-a794-c1020d254c2d
https://research.rug.nl/en/publications/69ec7c24-43b8-44b2-a794-c1020d254c2d